CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-208

Investor sentiment seemed pretty reasonable whilst I've been doing my research, which is a factor I give some thought when deciding what price I'm willing to pay... But only a small thought.

Looking back over previous reports and presentations it's good to see management have followed up on their goals, firstly with a strong emphasis on pushing hard into the US market and now starting to expand further into othe markets (western Europe, Asia, Canada) as the revenue is increasing.

With the strong increasing revenue of quality proven products, cash to spend on marketing and potential financial windfall that 2RT could provide I'm happy to have dipped my toes in the water. If we see more red it will create a better point to increase my position.

Happy to wait and see!